HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).

Abstract
The pattern and amount of blood loss following induction of therapeutic abortion using mifepristone (RU 486) and a prostaglandin E analogue (gemeprost) was studied in 222 women of less than 63 days amenorrhoea. A single oral dose of mifepristone (400, 500 or 600 mg) was followed 48 hours later by a half or 1 mg gemeprost vaginal pessary. Complete abortion occurred in 218 (98%) women without necessity for surgical evacuation of the uterus. Bleeding commonly occurred following administration of mifepristone and prior to prostaglandin administration. The median duration of bleeding following abortion was 13 days with a range of from 1 to 44 days. There was a wide individual variation in measured blood loss between women, from 14 to 512 ml, with a median loss of 74 ml. The amount of blood loss was independent of the dose of mifepristone or prostaglandin but was significantly correlated with gestation. These results confirm that the combination of mifepristone and gemeprost is a highly effective and safe method of inducing therapeutic abortion medically. As the amount of blood loss increases with increasing gestation, it is suggested that its use should be restricted to women with amenorrhoea less than or equal to 56 days.
AuthorsM W Rodger, D T Baird
JournalContraception (Contraception) Vol. 40 Issue 4 Pg. 439-47 (Oct 1989) ISSN: 0010-7824 [Print] United States
PMID2582769 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Abortifacient Agents
  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Mifepristone
  • gemeprost
  • Alprostadil
Topics
  • Abortifacient Agents
  • Abortifacient Agents, Nonsteroidal
  • Abortifacient Agents, Steroidal
  • Abortion, Therapeutic (adverse effects)
  • Alprostadil
  • Drug Therapy, Combination
  • Female
  • Humans
  • Mifepristone
  • Pregnancy
  • Pregnancy Trimester, First
  • Premedication
  • Uterine Hemorrhage (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: